Publication|Articles|September 18, 2025

Supplements and Featured Publications

  • Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data

Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data

Key Takeaways

  • Zevra Therapeutics emphasizes innovative treatments and emerging technologies in oncology to improve patient outcomes.
  • Collaboration between pharmaceutical companies and healthcare professionals is crucial for accelerating effective cancer therapy development.
SHOW MORE

This clinical brief is sponsored by Zevra Therapeutics.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo